Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer

被引:110
作者
Martin, RCG
Chagpar, A
Scoggins, CR
Edwards, MJ
Hagendoorn, L
Stromberg, AJ
McMasters, KM
机构
[1] Univ Louisville, Dept Surg, Div Surg Oncol, J Graham Brown Canc Ctr, Louisville, KY 40202 USA
[2] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA
[3] Advertek Inc, Louisville, KY USA
[4] Univ Kentucky, Dept Stat, Lexington, KY 40506 USA
关键词
D O I
10.1097/01.sla.0000165200.32722.02
中图分类号
R61 [外科手术学];
学科分类号
摘要
Summ. Background Data: Previous studies have suggested a variety of factors that may affect the false negative (FN) rate for sentinel lymph node (SLN) biopsy in breast cancer. Because FN results are relatively rare, no prior studies have had sufficient sample size to allow detailed statistical analysis of factors predicting FN results. Methods: Patients with clinical stage T1-2, NO invasive breast cancer were enrolled in a prospective, multicenter study. All patients underwent SLN biopsy, followed by planned completion axillary dissection regardless of the SLN results, to assess the FN rate. SLN biopsy was performed using radioactive colloid injection in combination with isosulfan blue dye in 94% of cases. Dermal, subdermal, peritumoral, or subareolar radioactive colloid injection techniques were used at the discretion of each institution. Univariate and multivariate analyses were performed to identify factors associated with a FN result. Results: SLNs were identified in 3870 of 4117 patients (94%). There were 1243 true positive, 2521 true negative, and 106 FN results. Age, histologic subtype, the number of non-SLN removed, tumor palpability, type of breast biopsy, and SLN injection technique were not significant factors. On multivariate analysis, tumor size < 2.5 cm, upper outer quadrant tumor location, removal of only a single SLN, minimal surgeon experience, presence of a single positive axillary LN, and use of immunohistochemistry (IHC) for SLN analysis were independently associated with an increased risk of FN results. Conclusions: Surgeon experience, tumor size and location, and the number of SLN removed are preoperative and intraoperative factors that independently predict the risk of a FN result. In contrast to suggestions from other smaller studies, age does not affect the likelihood of a FN result; a lesser, rather than greater, number of positive axillary nodes was associated with an increased likelihood of a IN result; and IHC analysis of the SLN increases, rather than decreases, the risk of IN results.
引用
收藏
页码:1005 / 1012
页数:8
相关论文
共 53 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]  
Bedrosian I, 2000, CANCER, V88, P2540, DOI 10.1002/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO
[3]  
2-A
[4]   Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection [J].
Borgstein, P ;
Pijpers, R ;
Comans, EF ;
van Diest, PJ ;
Boom, RP ;
Meijer, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :275-283
[5]   Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy [J].
Chagpar, A ;
Martin, RC ;
Chao, C ;
Wong, SL ;
Edwards, MJ ;
Tuttle, T ;
McMasters, KM .
ARCHIVES OF SURGERY, 2004, 139 (06) :614-618
[6]   Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast [J].
Chao, C ;
Wong, SL ;
Woo, C ;
Edwards, MJ ;
Tuttle, T ;
Noyes, RD ;
Carlson, DJ ;
Turk, P ;
Simpson, D ;
McMasters, KM .
AMERICAN JOURNAL OF SURGERY, 2001, 182 (04) :307-311
[7]   Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis [J].
Chu, KU ;
Turner, RR ;
Hansen, NM ;
Brennan, MB ;
Giuliano, AE .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) :756-761
[8]   Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001 [J].
Chua, B ;
Olivotto, IA ;
Donald, JC ;
Hayashi, AH ;
Doris, PJ ;
Turner, LJ ;
Cuddington, GD ;
Davis, NL ;
Rusnak, CH .
AMERICAN JOURNAL OF SURGERY, 2003, 185 (02) :118-126
[9]   Role for sentinel lymph node dissection in the management of large (≥5 cm) invasive breast cancer [J].
Chung, MH ;
Ye, W ;
Giuliano, AE .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (09) :688-692
[10]  
Cody HS, 1999, ONCOLOGY-NY, V13, P25